Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
OP0072 INHIBITION OF CLK2 AND DYRK1A BY SM04690 AS A NOVEL MOLECULAR ...
Figure S1. SM04690 induces YAP dependent proliferation at non-toxic ...
SM04690 induced chondrocyte differentiation from hMSCs. (a) hMSCs ...
SM04690 induced chondrocyte differentiation from hMSCs. hMSCs, ATDC5 ...
Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 “Pain ...
Inhibition of CLK2 by SM04690 induces alternative splicing of Hippo ...
OP0061 Treatment of knee osteoarthritis with sm04690 improved womac a1 ...
SM04690 increases cartilage thickness relative to control in rat ...
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04690) As ...
Adavivint (SM04690) | Wnt/beta-catenin 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400 ...
Adavivint (SM04690) | Wnt Pathway 阻害剤 | MedChemExpress
Adavivint(SM04690;Lorecivivint)
Discovery of an Intra-Articular Injection Small Molecule Inhibitor of ...
Alternative splicing of AMOTL2 promotes delocalization from the ...
A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential ...
Lorecivivint (SM04690) was a potent inhibitor of CLKs and DYRK1A. (a ...
Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of ...
A Small Molecule, SM04690, Has Inhibitory Effects on the Wnt Pathway ...
SM04690, a WNT pathway inhibitor: anti-inflammatory and cartilage ...
Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as ...
SM04690, A potential disease-modifying treatment for knee ...
A small-molecule inhibitor of the Wnt pathway, lorecivivint (SM04690 ...
Lorecivivint (Adavivint, SM04690) | CLK2 inhibitor | Probechem Biochemicals
Stem Cell - Signaling Pathways
The Novel, Intra-articular CLK/DYRK1A Inhibitor Lorecivivint (LOR ...
FRI0552 Sm04690, a wnt pathway inhibitor: anti-inflammatory and ...
Efficacy and safety from a phase 2B trial of SM04690, a novel, intra ...
Lorecivivint (SM04690), a Potential Disease-Modifying Osteoarthritis ...
Wnt/beta-catenin抑制剂 | Wnt/beta-catenin Inhibitor
Joint space width inclusion criteria can reduce knee osteoarthritis ...
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate ...
Reducing Heterogeneity in OA Clinical Trials: Data from a Phase 2 Study ...
OP0166 Radiographic outcomes from a randomized, double-blind, placebo ...
OP0137 OPTIMIZING SUBJECT SELECTION IN KNEE OSTEOARTHRITIS CLINICAL ...
SAT0428 Safety, Clinical and Imaging Outcomes of A Novel, Intra ...
SAT0549 Anti-inflammatory properties of SM04690, a small molecule ...
Results from a 52-week randomized, double-blind, placebo-controlled ...
AB0070 LORECIVIVINT (SM04690), A POTENTIAL DISEASE-MODIFYING TREATMENT ...
(PDF) A Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a ...
FRI0534 Radiographic outcomes were associated with pain and function ...
Radiographic Outcomes Were Associated with Pain and Function Responses ...
Lorecivivint (SM04690), a potential disease-modifying treatment for ...
Adavivint (SM04690) | Wnt/beta-catenin 阻害剤
Lorecivivint (SM04690): modulatore Wnt intra-articolare per l’artrosi ...
THU0414 COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTIONS FROM ...
Assessment of Health-Related Quality of Life in a 52-Week, Phase 2 ...
SAT0552 Clinical outcomes from a randomized, double-blind, placebo ...
(PDF) AB0069 LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE ...
POS0372 LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK2 ...
Comparison of intra-articular sham and vehicle injection from a phase ...
Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular ...
(PDF) POS0372 LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL ...
Adavivint (SM04690; Lorecivivint) | CAS 1467093-03-3 | AbMole ...
Lorecivivint (SM04690), an Intra-articular, Small-Molecule CLK/DYRK ...
Results from a 52 Week Randomized, Double-Blind, Placebo-Controlled ...
Magnetic Resonance Imaging Outcomes Using an Intra-Articular Injection ...
OP0069 Discovery of A Small Molecule Inhibitor of The WNT Pathway ...
OP0188 INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT ...
(PDF) A Small-Molecule Inhibitor of the Wnt Pathway, Lorecivivint ...
Osteoarthritis (OA) Models - Cellomatics Biosciences
Radiographic Outcomes from a Randomized, Double-Blind, Placebo ...
Radiographic outcomes were concordant with outcome measures in ...
FRI0430 THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT ...
Samumed Presents Data for a Small Molecule Modulator of Wnt Pathway as ...
CXCR | CXC趋化因子受体 | 拮抗剂 | MCE
Samumed Begins Phase 3 Lorecivivint (SM04690) Trial of Regenerative ...
Safety Profile to Date of the Novel, Intra-articular Agent Lorecivivint ...
Subject Enrichment Criteria for Phase 3 Studies of Lorecivivint ...
OMERACT-OARSI ‘strict responders’ analysis from results of a randomized ...
